BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, Peligro PJ, Casimiro M, Guerrero JJ, Gellaco MML, Lippi G, Henry BM, Fernández-de-Las-Peñas C. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine 2022;53:101624. [PMID: 36051247 DOI: 10.1016/j.eclinm.2022.101624] [Cited by in Crossref: 60] [Cited by in F6Publishing: 9] [Article Influence: 60.0] [Reference Citation Analysis]
Number Citing Articles
1 Morello R, Martino L, Buonsenso D. Diagnosis and management of post-COVID (Long COVID) in children: a moving target. Curr Opin Pediatr 2023;35:184-92. [PMID: 36660968 DOI: 10.1097/MOP.0000000000001221] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Di Fusco M, Marczell K, Thoburn E, Wiemken TL, Yang J, Yarnoff B. Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (original and omicron BA.4/BA.5) in the United States. J Med Econ 2023;:1-25. [PMID: 36942976 DOI: 10.1080/13696998.2023.2193067] [Reference Citation Analysis]
3 Di Fusco M, Sun X, Moran MM, Coetzer H, Zamparo JM, Alvarez MB, Puzniak L, Tabak YP, Cappelleri JC. Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron.. [DOI: 10.1101/2023.03.15.23286981] [Reference Citation Analysis]
4 Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine 2023;41:1783-90. [PMID: 36774332 DOI: 10.1016/j.vaccine.2023.02.008] [Reference Citation Analysis]
5 Scharf RE, Anaya J. Post-COVID Syndrome in Adults—An Overview. Viruses 2023;15:675. [DOI: 10.3390/v15030675] [Reference Citation Analysis]
6 Lulli LG, Baldassarre A, Chiarelli A, Mariniello A, Paolini D, Grazzini M, Mucci N, Arcangeli G. Physical Impact of SARS-CoV-2 Infection in a Population of Italian Healthcare Workers. Int J Environ Res Public Health 2023;20. [PMID: 36901516 DOI: 10.3390/ijerph20054506] [Reference Citation Analysis]
7 Matsumoto C, Shibata S, Kishi T, Morimoto S, Mogi M, Yamamoto K, Kobayashi K, Tanaka M, Asayama K, Yamamoto E, Nakagami H, Hoshide S, Mukoyama M, Kario K, Node K, Rakugi H. Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19. Hypertens Res 2023;46:601-19. [PMID: 36575228 DOI: 10.1038/s41440-022-01145-2] [Reference Citation Analysis]
8 Yin X, Popa H, Stapon A, Bouda E, Garcia-Diaz M. Fidelity of Ribonucleotide Incorporation by the SARS-CoV-2 Replication Complex. J Mol Biol 2023;435:167973. [PMID: 36690070 DOI: 10.1016/j.jmb.2023.167973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Rosenberg A, Sawhney M, Bernstein HH, Romero JR. COVID-19 Vaccines for Children: An Update. Pediatr Ann 2023;52:e83-8. [PMID: 36881800 DOI: 10.3928/19382359-20230119-01] [Reference Citation Analysis]
10 Hernández-Aceituno A, García-Hernández A, Larumbe-Zabala E. COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants. Infect Dis Now 2023;:104688. [PMID: 36858287 DOI: 10.1016/j.idnow.2023.104688] [Reference Citation Analysis]
11 Gaspar P, Dias M, Parreira I, Gonçalves HD, Parlato F, Maione V, Atalaia Barbacena H, Carreiro C, Duarte L. Predictors of Long-COVID-19 and its Impact on Quality of Life: Longitudinal Analysis at 3, 6 and 9 Months after Discharge from a Portuguese Centre. Acta Med Port 2023. [PMID: 36827994 DOI: 10.20344/amp.19047] [Reference Citation Analysis]
12 Wahlgren C, Forsberg G, Divanoglou A, Östholm Balkhed Å, Niward K, Berg S, Levi R. Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study. Lancet Reg Health Eur 2023;:100595. [PMID: 36855599 DOI: 10.1016/j.lanepe.2023.100595] [Reference Citation Analysis]
13 Varma JK, Zang C, Carton TW, Block JP, Khullar DJ, Zhang Y, Weiner MG, Rothman RL, Schenck EJ, Xu Z, Lyman K, Bian J, Xu J, Shenkman EA, Maughan C, Castro-Baucom L, Oâ Brien L, Wang F, Kaushal R. Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER Program. medRxiv 2023:2023. [PMID: 36865304 DOI: 10.1101/2023.02.15.23286012] [Reference Citation Analysis]
14 Ballouz T, Menges D, Kaufmann M, Amati R, Frei A, von Wyl V, Fehr JS, Albanese E, Puhan MA. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts. PLoS One 2023;18:e0281429. [PMID: 36812215 DOI: 10.1371/journal.pone.0281429] [Reference Citation Analysis]
15 Salfi F, Amicucci G, Corigliano D, Viselli L, D’atri A, Tempesta D, Ferrara M. Poor sleep quality, insomnia, and short sleep duration before infection predict long-term symptoms after COVID-19.. [DOI: 10.1101/2023.02.13.23285859] [Reference Citation Analysis]
16 Zavori L, Molnar T, Varnai R, Kanizsai A, Nagy L, Vadkerti B, Szirmay B, Schwarcz A, Csecsei P. Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome. J Pers Med 2023;13. [PMID: 36836605 DOI: 10.3390/jpm13020371] [Reference Citation Analysis]
17 Hernández Arroyo J, Izquierdo-Condoy JS, Ortiz-Prado E. A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme. Vaccines (Basel) 2023;11. [PMID: 36851320 DOI: 10.3390/vaccines11020444] [Reference Citation Analysis]
18 Nascimento TCDC, do Valle Costa L, Ruiz AD, Ledo CB, Fernandes VPL, Cardoso LF, Junior JMV, Saretta R, Kalil-Filho R, Drager LF. Vaccination status and long COVID symptoms in patients discharged from hospital. Sci Rep 2023;13:2481. [PMID: 36774419 DOI: 10.1038/s41598-023-28839-y] [Reference Citation Analysis]
19 Fabbri A, Voza A, Riccardi A, Vanni S, De Iaco F; Study & Research Center of the Italian Society of Emergency Medicine (SIMEU). Unfavorable Outcome and Long-Term Sequelae in Cases with Severe COVID-19. Viruses 2023;15. [PMID: 36851699 DOI: 10.3390/v15020485] [Reference Citation Analysis]
20 Merza MA, Almufty HB, Younis HA, Rasool SO, Mohammed SA. Memory impairment among recovered COVID-19 patients: The prevalence and risk factors, a retrospective cohort study. J Med Virol 2023;95:e28459. [PMID: 36602051 DOI: 10.1002/jmv.28459] [Reference Citation Analysis]
21 Fernández-de-Las-Peñas C, Cuadrado ML, Gómez-Mayordomo V, García-Azorín D, Arendt-Nielsen L. Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant. Expert Rev Neurother 2023;23:179-86. [PMID: 36857191 DOI: 10.1080/14737175.2023.2185138] [Reference Citation Analysis]
22 Al-Shami I, Hourani HMA, Alkhatib B. The use of prognostic nutritional index (PNI) and selected inflammatory indicators for predicting malnutrition in COVID-19 patients: A retrospective study. J Infect Public Health 2023;16:280-5. [PMID: 36623422 DOI: 10.1016/j.jiph.2022.12.018] [Reference Citation Analysis]
23 Sakurada Y, Otsuka Y, Tokumasu K, Sunada N, Honda H, Nakano Y, Matsuda Y, Hasegawa T, Ochi K, Hagiya H, Ueda K, Kataoka H, Otsuka F. Trends in Long COVID Symptoms in Japanese Teenage Patients. Medicina (Kaunas) 2023;59. [PMID: 36837463 DOI: 10.3390/medicina59020261] [Reference Citation Analysis]
24 Elmazny A, Magdy R, Hussein M, Elsebaie EH, Ali SH, Abdel Fattah AM, Hassan M, Yassin A, Mahfouz NA, Elsayed RM, Fathy W, Abdel-Hamid HM, Abdelbadie M, Soliman SH. Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination. Eur Arch Psychiatry Clin Neurosci 2023;:1-10. [PMID: 36707454 DOI: 10.1007/s00406-023-01557-2] [Reference Citation Analysis]
25 Hallek M, Adorjan K, Behrends U, Ertl G, Suttorp N, Lehmann C. Post-COVID Syndrome. Dtsch Arztebl Int 2023;120:48-55. [PMID: 36633452 DOI: 10.3238/arztebl.m2022.0409] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Herting A, Jahnke-Triankowski J, Harberts A, Schaub GM, Lütgehetmann M, Ruether DF, Fischer L, Addo MM, Lohse AW, Schulze Zur Wiesch J, Sterneck M. Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron Wave. Viruses 2023;15. [PMID: 36851510 DOI: 10.3390/v15020297] [Reference Citation Analysis]
27 Albakri K, Khaity A, Atwan H, Saleh O, Al-Hajali M, Cadri S, Diab RA, Albazee E, Negida A. Bell's Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis. Vaccines (Basel) 2023;11. [PMID: 36851114 DOI: 10.3390/vaccines11020236] [Reference Citation Analysis]
28 Ho FF, Xu S, Kwong TMH, Li AS, Ha EH, Hua H, Liong C, Leung KC, Leung TH, Lin Z, Wong SY, Pan F, Chung VCH. Prevalence, Patterns, and Clinical Severity of Long COVID among Chinese Medicine Telemedicine Service Users: Preliminary Results from a Cross-Sectional Study. Int J Environ Res Public Health 2023;20. [PMID: 36767195 DOI: 10.3390/ijerph20031827] [Reference Citation Analysis]
29 Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C, Selemon A, Whelan M, Premji Z, Issa H, Cheng B, Abu Raddad LJ, Buckeridge DL, Van Kerkhove MD, Piechotta V, Higdon MM, Wilder-Smith A, Bergeri I, Feikin DR, Arora RK, Patel MK, Subissi L. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis 2023:S1473-3099(22)00801-5. [PMID: 36681084 DOI: 10.1016/S1473-3099(22)00801-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 13.0] [Reference Citation Analysis]
30 Romero-Rodríguez E, Perula-de-Torres LÁ, González-Lama J, Castro-Jiménez RÁ, Jiménez-García C, Priego-Pérez C, Vélez-Santamaría R, Simón-Vicente L, González-Santos J, González-Bernal JJ. Long COVID Symptomatology and Associated Factors in Primary Care Patients: The EPICOVID-AP21 Study. Healthcare (Basel) 2023;11. [PMID: 36673587 DOI: 10.3390/healthcare11020218] [Reference Citation Analysis]
31 Guzman-Esquivel J, Mendoza-Hernandez MA, Guzman-Solorzano HP, Sarmiento-Hernandez KA, Rodriguez-Sanchez IP, Martinez-Fierro ML, Paz-Michel BA, Murillo-Zamora E, Rojas-Larios F, Lugo-Trampe A, Plata-Florenzano JE, Delgado-Machuca M, Delgado-Enciso I. Clinical Characteristics in the Acute Phase of COVID-19 That Predict Long COVID: Tachycardia, Myalgias, Severity, and Use of Antibiotics as Main Risk Factors, While Education and Blood Group B Are Protective. Healthcare (Basel) 2023;11. [PMID: 36673565 DOI: 10.3390/healthcare11020197] [Reference Citation Analysis]
32 Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med 2023;2:e000385. [PMID: 36936268 DOI: 10.1136/bmjmed-2022-000385] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Schultheiß C, Willscher E, Paschold L, Gottschick C, Klee B, Bosurgi L, Dutzmann J, Sedding D, Frese T, Girndt M, Höll JI, Gekle M, Mikolajczyk R, Binder M. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. J Med Virol 2023;95:e28364. [PMID: 36458566 DOI: 10.1002/jmv.28364] [Reference Citation Analysis]
34 Viet-Thi Tran, Elodie Perrodeau, Julia Saldanha, Isabelle Pane, Philippe Ravaud. Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort. BMJ Med 2023;2:e000229. [PMID: 36910458 DOI: 10.1136/bmjmed-2022-000229] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Binns CW, Lee MK, Doan TTD, Lee A, Pham M, Zhao Y. COVID and Gender: A Narrative Review of the Asia-Pacific Region. Int J Environ Res Public Health 2022;20. [PMID: 36612567 DOI: 10.3390/ijerph20010245] [Reference Citation Analysis]
36 Miskowiak KW, Bech JL, Henriksen AC, Johnsen S, Podlekareva D, Marner L. Cerebral Metabolic Rate of Glucose and Cognitive Tests in Long COVID Patients. Brain Sci 2022;13. [PMID: 36672005 DOI: 10.3390/brainsci13010023] [Reference Citation Analysis]
37 Haque A, Pant AB. Long Covid: Untangling the Complex Syndrome and the Search for Therapeutics. Viruses 2022;15. [PMID: 36680082 DOI: 10.3390/v15010042] [Reference Citation Analysis]
38 Arjun MC, Singh AK, Pal D, Das K, G A, Venkateshan M, Mishra B, Patro BK, Mohapatra PR, Subba SH. Characteristics and predictors of Long COVID among diagnosed cases of COVID-19. PLoS One 2022;17:e0278825. [PMID: 36538532 DOI: 10.1371/journal.pone.0278825] [Reference Citation Analysis]
39 Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, Punzi V, Luotti S, Bottino N, Biagianti B, Moglia C, Fuda G, Gualtierotti R, Blasi F, Canetta C, Montano N, Tettamanti M, Camera G, Grimoldi M, Negro G, Rifino N, Calvo A, Brambilla P, Biroli F, Bandera A, Nobili A, Stocchetti N, Sessa M, Zanier ER. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front Immunol 2022;13:1070379. [PMID: 36591311 DOI: 10.3389/fimmu.2022.1070379] [Reference Citation Analysis]
40 Yang C, Zhao H, Shannon CP, Tebbutt SJ. Omicron variants of SARS-CoV-2 and long COVID. Front Immunol 2022;13:1061686. [PMID: 36569883 DOI: 10.3389/fimmu.2022.1061686] [Reference Citation Analysis]
41 Cimellaro A, Addesi D, Cavallo M, Spagnolo F, Suraci E, Cordaro R, Spinelli I, Passafaro F, Colosimo M, Pintaudi M, Pintaudi C, On Behalf Of The CATAnzaro LOng Covid Cataloco Study Group. Monoclonal Antibodies and Antivirals against SARS-CoV-2 Reduce the Risk of Long COVID: A Retrospective Propensity Score-Matched Case-Control Study. Biomedicines 2022;10. [PMID: 36551891 DOI: 10.3390/biomedicines10123135] [Reference Citation Analysis]
42 Fernández-de-Las-Peñas C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, Arendt-Nielsen L, Torres-Macho J, Plaza-Manzano G. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature. Viruses 2022;14. [PMID: 36560633 DOI: 10.3390/v14122629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
43 Khong K, Zhang R, Hung IF. The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What. Vaccines 2022;10:1924. [DOI: 10.3390/vaccines10111924] [Reference Citation Analysis]
44 Fernández-de-Las-Peñas C, Rodríguez-Jiménez J, Cancela-Cilleruelo I, Guerrero-Peral A, Martín-Guerrero JD, García-Azorín D, Cornejo-Mazzuchelli A, Hernández-Barrera V, Pellicer-Valero OJ. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients. JAMA Netw Open 2022;5:e2242106. [PMID: 36378309 DOI: 10.1001/jamanetworkopen.2022.42106] [Cited by in Crossref: 9] [Article Influence: 9.0] [Reference Citation Analysis]
45 Fernández-de-las-peñas C, Arendt-nielsen L, Díaz-gil G, Gómez-esquer F, Gil-crujera A, Gómez-sánchez SM, Ambite-quesada S, Palomar-gallego MA, Pellicer-valero OJ, Giordano R. Genetic Association between ACE2 (rs2285666 and rs2074192) and TMPRSS2 (rs12329760 and rs2070788) Polymorphisms with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors. Genes 2022;13:1935. [DOI: 10.3390/genes13111935] [Reference Citation Analysis]
46 Hung CH, Wei JC. Long COVID symptoms survey and methodological issue. Pharmacol Res 2022;:106485. [PMID: 36195306 DOI: 10.1016/j.phrs.2022.106485] [Reference Citation Analysis]
47 Santulli G, Trimarco V, Trimarco B, Izzo R. Beneficial Effects of Vitamin C and L-Arginine in the Treatment of Post-Acute Sequelae of COVID-19. Pharmacol Res 2022;:106479. [PMID: 36191881 DOI: 10.1016/j.phrs.2022.106479] [Reference Citation Analysis]
48 Gao P, Liu J, Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2022;19. [PMID: 36231717 DOI: 10.3390/ijerph191912422] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
49 Ballouz T, Menges D, Kaufmann M, Amati R, Frei A, von Wyl V, Fehr JS, Albanese E, Puhan MA. Post COVID-19 condition after Wildtype, Delta, and Omicron variant SARS-CoV-2 infection and vaccination: pooled analysis of two population-based cohorts.. [DOI: 10.1101/2022.09.25.22280333] [Reference Citation Analysis]
50 Davidson BS, Noteboom L, Pierro H, Kantor C, Stoot D, Stoot F, Linseman D, Hale T, Gorgens K. Post-Concussion Assessment as a diagnostic and mechanistic framework for treating patients with Long COVID.. [DOI: 10.1101/2022.09.24.22280310] [Reference Citation Analysis]
51 Fernández-de-Las-Peñas C, Giordano R, Díaz-Gil G, Gómez-Esquer F, Ambite-Quesada S, Palomar-Gallego MA, Arendt-Nielsen L. Post-COVID Pain Is Not Associated with Inflammatory Polymorphisms in People Who Had Been Hospitalized by COVID-19. J Clin Med 2022;11. [PMID: 36233516 DOI: 10.3390/jcm11195645] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Nascimento TCDC, Costa LV, Ruiz AD, Ledo CB, Fernandes VPL, Cardoso LF, Vieira JM, Saretta R, Kalil-filho R, Drager LF. Vaccination Status and Long COVID Symptoms in Patients Discharged from Hospital.. [DOI: 10.21203/rs.3.rs-2050152/v1] [Reference Citation Analysis]
53 Fernández-de-las-peñas C, Ortega-santiago R, Fuensalida-novo S, Martín-guerrero JD, Pellicer-valero OJ, Torres-macho J. Differences in Long-COVID Symptoms between Vaccinated and Non-Vaccinated (BNT162b2 Vaccine) Hospitalized COVID-19 Survivors Infected with the Delta Variant. Vaccines 2022;10:1481. [DOI: 10.3390/vaccines10091481] [Reference Citation Analysis]